Earnings Call · Q2 FY2025·2025-08-04

Q2 25EPS -10.42%·Rev n/aQ1 25EPS -21.05%·Rev n/aQ4 24EPS -17.39%·Rev n/aQ3 24EPS +1.11%·Rev n/a⚠ consensus missing

Krystal Biotech, Inc. KRYS

Stephane Paquette — Vice President of Corporate Development

Laurent Goux — Head of European Operations

Krish S. Krishnan — Chief Executive Officer

Suma M. Krishnan — Chief Scientific Officer

Kathryn A. Romano — Chief Financial Officer

−14.0%1d on move date−15.6% vs SPY3d−13.4%5d−11.7%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KRYS calls or request research access.

More KRYS calls Browse calls Request research access